ClinicalTrials.gg
RecruitingNCT07310953EVN/EDAFUpdated Feb 18, 2026

Clinical Utility of the Numerical Verbal Scale (NVS) and the Pain and Functional Activity Scale (PFAS) in the Management of Rescue Analgesia in Acute Postoperative Pain. Randomized Study.

An interventional study of Group A: Rescue analgesia if NVS>4 and Group B: Rescue analgesia if NVSm > 4 + FAS C in Analgesia, Post Operative Pain and Acute Pain, sponsored by Fundacin Biomedica Galicia Sur. Recruiting at 1 site in Spain. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-18.

Sponsored by Fundacin Biomedica Galicia Sur · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2026, 3 months ago, but the record still lists the study as recruiting.
  • Started Oct 2025; still recruiting 1 year later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
76
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 86 studies in Pain, Postoperative with a site in Spain — 18 open to participants now, 23 under way, 1 of them phase 3. Pain, Postoperative · Spain.

Planned enrollment
38th of 60
76 · median 90
Started
2025
with 5 others
No phase
30 of 86
13 open now
Primary completion
2026-07
later than 13 of 22 live
Registered
81st of 86
by date

Among the 86 studies in Pain, Postoperative with a site in Spain, this one is the 38th largest by planned enrollment of the 60 interventional ones that give a count, is one of 6 that started in 2025, is one of 30 with no phase, reaches primary completion later than 13 of the 22 other live ones, and was the 81st registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

18 of the 86 studies in Pain, Postoperative with a site in Spain are open now. Recruiting first, the newest first:

12 more — sign in →

All 18 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 86 studies in Pain, Postoperative with a site in Spain, or all of them as a file.
02

Study summary

Adequate postoperative pain management, along with mobilization and early oral nutrition, is the foundation for optimal recovery after surgery.

Unidimensional pain scales (Numerical Verbal Rating Scale - NRS, Visual Analogue Scale - VAS, Categorical Scale - CRS, Facial Pain Scale - FPS) do not adequately reflect a patient's actual analgesic needs. Basing analgesic treatment on the classic algorithm of administering opioids if pain is greater than 4 on the NRS, without considering functional impairment, has been shown to be a cause of overtreatment in surgical wards.

The Functional Activity Score (FAS) is the simplest scale, designed for bedside application and geared toward therapeutic decision-making. R: Able to perform any activity; B: Pain prevents some activity; C: Unable to perform any activity.

Given the need to standardize functional limitation when measuring postoperative pain, we propose the Pain and Functional Activity Scale (PFAS), which combines the NVA (Non-Visual Analogue Scale) with the Functional Activity Scale. Specifically, pain on movement would be recorded using the NVA in motion (NVAm), along with functional limitation (A, B, or C). The rescue analgesia treatment algorithm adapted to the PFAS would involve treating patients with pain greater than 4 on the NVA whenever it represents a severe limitation of their functional activity (C).

In this study, we aim to evaluate whether there are significant differences in the proportion of patients who meet the criteria for needing rescue analgesia according to the NVA compared to the proportion of patients who meet the criteria for needing rescue analgesia established by the PFAS, during the 2-day postoperative period.

To this end, an experimental, longitudinal, prospective, randomized, single-blind study for the data analyzer will be carried out, where a group that will receive rescue analgesia if VNS>4 and another if VNSm>4 + FAS C will be compared in the first two days of postoperative surgical patients of the surgeries selected in the EOXI of Vigo.

03

Conditions studied

  • Analgesia
  • Post Operative Pain
  • Acute Pain
  • Functional; Anesthesia

Keywords

  • numerical verbal scale
  • Functional Activity Score
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Scheduled surgery with VATS admission
  • Age > 18 years
  • Signed

Exclusion criteria

Exclusion Criteria:

  • Cognitive-mental deficit assessed using the Pfeiffer questionnaire. Patients with more than two errors if they have a university degree and more than three errors if they do not have a university degree are excluded from the study.
  • Allergy to any of the analgesic drugs listed on the data collection sheet (Paracetamol / NSAIDs / Metamizole / Dexamethasone / Local anesthetics / Morphine / Fentanyl).
  • Patients who, in the preoperative survey, present any degree of functional limitation according to the FAS scale (Grade B and C).

Withdrawal Criteria:

  • If the patient withdraws consent.
  • If the patient experiences delirium, as measured by a positive CAM (Confusion Assessment Method) scale, following surgery.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
76 participants (estimated)

Study arms

  • Active comparator
    Group A

    Rescue analgesia if EVN\>4

    Procedure: Group A: Rescue analgesia if NVS>4

  • Experimental
    Group B

    Rescue analgesia if EVNm \>4 + FAS C

    Procedure: Group B: Rescue analgesia if NVSm > 4 + FAS C

Interventions

  • ProcedureGroup A: Rescue analgesia if NVS>4

    Rescue analgesia will be self-administered by the patient, when post-surgical pain is moderate to severe, using morphine PCA at a dose of 0.075 mg/kg maximum every 15 minutes, up to a maximum of 3 times per hour, provided they meet the criteria described for the group to which they have been assigned.

  • ProcedureGroup B: Rescue analgesia if NVSm > 4 + FAS C

    Rescue analgesia will be self-administered by the patient, when post-surgical pain is moderate to severe and this pain interferes with and limits functional activity, using morphine PCA at a dose of 0.075 mg/kg maximum every 15 minutes, up to a maximum of 3 times per hour, provided they meet the criteria described for the group to which they have been assigned.

06

What researchers measure

Primary outcomes

  1. NVS

    Resting Numerical Verbal Scale (NVS), indicate one of the following options (0 = no pain 10 = the worst pain imaginable): 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10.

    Time frame: Day 0 (before the surgical intervention), at 24 and 48 hours and in case rescue analgesia is requested.

  2. mNVS

    Moving Numerical Verbal Scale (mNVS), indicate one of the following options (0 = no pain 10 = the worst pain imaginable): 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10.

    Time frame: Day 0 (before the surgical intervention), at 24 and 48 hours and in case rescue analgesia is requested.

  3. FAS

    Functional Activity Score (FAS): After evaluating the following activities: Sitting, Walking, Rehabilitation, Respiratory Physiotherapy; indicate how pain interferes with your functional activity and rank them from best to worst: * A: Able to perform any activity (performs all 4 activities without limitation) * B: Pain prevents some activity (unable to perform between 1 and 3 of the activities) * C: Unable to perform any activity (is unable to perform any of the activities)

    Time frame: Day 0 (before the surgical intervention), at 24 and 48 hours and in case rescue analgesia is requested.

Secondary outcomes

  1. Age

    Patient age in years

    Time frame: Day 0 (before the surgical intervention)

  2. Gender

    Patient gender (Female, Male)

    Time frame: Day 0 (before the surgical intervention)

  3. BMI

    Patient body mass index

    Time frame: Day 0 (before the surgical intervention)

  4. Pfeiffer

    Cognitive-mental deficit assessed according to the Pfeiffer questionnaire: 1\. What is today's date (day, month, year)? 2. What day of the week is it today? 3. Where are we now (place or building)? 4. What is your telephone number? (or your address if you don't have a telephone) 5. How old are you? 6. What is your birth year? 7. Who is the current Prime Minister? 8. Who was the previous Prime Minister? 9. What is your mother's second surname? 10. Subtract 3 each time from the number 20. Patients with more than 2 errors if they have a university degree and more than 3 errors if they do not have a university degree will be excluded from the study. After completing the questionnaire, the variable is recorded as yes/no.

    Time frame: Day 0 (before the surgical intervention)

  5. ASA

    Anesthetic risk scale (ASA), indicate one of the following options: 0-No risk, 1-Low risk, 2-Moderate risk, 3-High risk

    Time frame: Day 0 (before the surgical intervention)

  6. Risk factors associated with persistent postoperative pain

    Risk factors associated with persistent postoperative pain, indicate the following option(s): * Treatment with antidepressants * Treatment with anxiolytics/benzodiazepines * Catastrophizing (Yes: moderate-to-high risk/ No: low risk) \[The Pain Catastrophizing Scale - abbreviated PCS-4 - will be applied). (4-8 low risk; 9-12 moderate risk; 13-16 high risk) * Chronic preoperative pain \[NV \>4 for more than 3 months, in any location\] * Use of strong opioids and/or tramadol at doses greater than 60 mg/day for more than 3 months * History of use of opiates, cannabis, lysergic acid diethylamide (LSD), 3,4-methylenedioxymethamphetamine (MDMA) * History of alcohol consumption \>40 grams/day in men and \>20 grams/day in women

    Time frame: Day 0 (before the surgical intervention)

  7. Procedure

    Surgical procedure, indicate one of the following options: Upper lobectomy, Middle lobectomy, Lower lobectomy.

    Time frame: Day 1 (after the surgical intervention)

  8. Surgery location

    Surgery location, indicate one of the following options: Right, Left.

    Time frame: Day 1 (after the surgical intervention)

  9. Anesthetic technique

    Anesthetic technique, indicate one of the following options: Inhalational general anesthesia, Intravenous general anesthesia

    Time frame: Day 1 (after the surgical intervention)

  10. Intraoperative analgesia guidelines

    Intraoperative analgesia guidelines, choose the type of drug: Fentanyl, paracetamol, NSAIDs

    Time frame: Day 1 (after the surgical intervention)

  11. Confusión Assessment Method (CAM)

    Postoperative Neurological Status of the Patient by Confusión Assessment Method: 1. Acute Onset and Fluctuating Course 2. Inattention 3. Disorganized Thinking 4. Altered Level of Consciousness 1\. Alert (normal) 2. Vigilant (hyperalert, very sensitive to environmental stimuli) 3. Lethargic (inhibited, drowsy) 4. Stuporous (difficult to awaken) For a diagnosis of delirium, the first two criteria and at least one of the last two are necessary. After completing the questionnaire, the variable is recorded as yes/no.

    Time frame: at 24 and 48 hours

  12. Analgesia guidelines in the post-surgical intensive care unit

    Analgesia guidelines in the post-surgical intensive care unit, indicate * Rescue dose of morphine (PCA) * Total dose in mg

    Time frame: at 24 and 48 hours

  13. Side effects of analgesia

    Side effects of analgesia, indicate from the following options: * Nausea / Vomiting * Postoperative ileus \[Oral intolerance and/or need for nasogastric tube\] * Mental confusion / Hallucinations * Sedation \[Ramsey Scale\] see appendix. * Pruritus * Respiratory depression \[Respiratory rate \< 12 breaths/min, requiring therapeutic maneuvers\] * Other (specify)

    Time frame: at 24 and 48 hours

  14. Nighttime rest

    Nighttime rest at 24 and 48 hours: Sleep scale. To answer the question "How do I sleep?" the patient responds on a scale from 0 (I don't sleep at all) to 10 (I sleep perfectly).

    Time frame: at 24 and 48 hours

  15. Desire for more analgesia

    Desire for more pain relief than received (Yes, No, Don't know)

    Time frame: at 48 hours

  16. Satisfaction with pain management therapy

    Satisfaction with pain management therapy using 4 categories: * Very dissatisfied * Dissatisfied * Satisfied * Very satisfied

    Time frame: at 48 hours

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2025 (actual). Primary completion is estimated for Jul 2026, 9 months after the start.

Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 9 months is below that.

Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 16, 2025
First posted
Dec 30, 2025
StartActual
Oct 30, 2025
Primary completionEst.
Jul 30, 2026
CompletionEst.
Sep 30, 2026
Last update
Feb 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07310953
Lead sponsor
Fundacin Biomedica Galicia Sur
Responsible party
Sponsor
First posted
Dec 30, 2025
Start date
Oct 30, 2025
Primary completion
Jul 30, 2026 (estimated)
Completion
Sep 30, 2026 (estimated)
Last update
Feb 18, 2026

Study contacts

Gustavo Illodo Miramontes, MD
Contact
gustavo.illodo.miramontes@sergas.es
986811111 ext. 16246

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion